H.R. 7047 · 117th Congress
Lowering Costs by Improving Biosimilar Uptake Act
- Stage
- In committee
- Sponsor
- Kurt Schrader
- Introduced
- 2022-03-09
- Latest action
- 2022-03-10 · Referred to the Subcommittee on Health.
Summary
Lowering Costs by Improving Biosimilar Uptake Act
This bill allows for the omission of certain information relating to the strength of a product in a biosimilar application, as determined by the Food and Drug Administration.